Statements (14)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:activeIngredient |
gptkb:THC
gptkb:CBD |
| gptkbp:clinicalTrialPhase |
gptkb:Australia
Phase II |
| gptkbp:developedBy |
gptkb:MGC_Pharmaceuticals
|
| gptkbp:form |
oral spray
|
| https://www.w3.org/2000/01/rdf-schema#label |
CogniCann
|
| gptkbp:intendedUse |
treatment of dementia symptoms
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:status |
investigational drug
|
| gptkbp:targetAudience |
patients with dementia
|
| gptkbp:bfsParent |
gptkb:MGC_Pharmaceuticals
|
| gptkbp:bfsLayer |
7
|